Teleflex sells Acute Care, Interventional Urology, and OEM businesses for $2.03B; authorizes $1B buyback

TELEFLEX INC

Total cash consideration $2.03B: OEM business to Montagu/Kohlberg for $1.5B; Acute Care and Interventional Urology to Intersurgical for $530M.
Net after-tax proceeds expected ~$1.8B; primarily used for share repurchases and debt reduction.
Board authorized $1B share repurchase program, funded from transaction proceeds.
Transactions expected to close in H2 2026, subject to regulatory approvals and customary conditions.
Teleflex will focus on remaining core businesses: Vascular Access, Interventional, and Surgical, targeting mid-single-digit growth.

item 1.01 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

TELEFLEX INC entered into OEM Agreement with Lotus US Bidco Inc. valued at $1,500,000,000 (effective 2025-12-09).

Action: entry
Agreement: asset purchase
Counterparty: Lotus US Bidco Inc.
Value: $1,500,000,000
Effective: 2025-12-09

Exact text from the filing

On December 9, 2025, Teleflex Incorporated (the “ Company ”) entered into an Equity Purchase Agreement (the “ OEM Agreement ”) with Lotus US Bidco Inc. (the “ OEM Purchaser ”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

TELEFLEX INC entered into Acute Care and Urology Agreement with Intersurgical Limited valued at $530,000,000 (effective 2025-12-09).

Action: entry
Agreement: asset purchase
Counterparty: Intersurgical Limited
Value: $530,000,000
Effective: 2025-12-09

Exact text from the filing

Also on December 9, 2025, the Company entered into an Equity Purchase Agreement (the “ Acute Care and Urology Agreement ”, and together with the OEM Agreement, the “ Agreements ”) with Intersurgical Limited (the “ Acute Care and Urology Purchaser ”).

View on SEC.gov

Browse all material agreements →

TELEFLEX INC filing history →

Source: SEC EDGAR

accession 0001193125-25-312941

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.